Gk Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-07-2024
- Paid Up Capital ₹ 0.30 M
as on 06-07-2024
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.00 Cr
as on 06-07-2024
- Revenue -72.78%
(FY 2022)
- Profit -2290.67%
(FY 2022)
- Ebitda -209.73%
(FY 2022)
- Net Worth -223.31%
(FY 2022)
- Total Assets -59.05%
(FY 2022)
About Gk Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M.
The company has closed loans amounting to ₹1.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Gautam Bhardwaj and Kapil Bhardwaj serve as directors at the Company.
- CIN/LLPIN
U24233MH2014PTC254015
- Company No.
254015
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Mar 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gk Remedies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gautam Bhardwaj  | Director | 10-Mar-2014 | Current |
| Kapil Bhardwaj | Director | 10-Mar-2014 | Current |
Financial Performance of Gk Remedies.
Gk Remedies Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 72.78% decrease. The company also saw a substantial fall in profitability, with a 2290.67% decrease in profit. The company's net worth observed a substantial decline by a decrease of 223.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gk Remedies?
In 2020, Gk Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shiva Biogenetic Pharmaceuticals Private LimitedActive 19 years 3 monthsKapil Bhardwaj is a mutual person
- Shiva Biogenetic Laboratories Private LimitedActive 8 years 5 months
Kapil Bhardwaj is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 11 Apr 2016 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Gk Remedies?
Unlock and access historical data on people associated with Gk Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gk Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gk Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
